Thu, 23/12/2010 - 10:49 by Dan Caplinger
Everyone would love to find the perfect stock. But will you ever really find a stock that gives you everythingyou could possibly want? One thing's for sure: If you don't look, you'll never find truly great investments. So let's first take a look at what you'd want to see from a perfect stock, and then decide if Transocean(NYSE: RIG) fits the bill.
Sat, 04/12/2010 - 09:35 by Rick Aristotle ...
Stupidity is contagious. It gets us all from time to time. Even respectable companies can catch it. As I do every week, let's take a look at five dumb financial events from the week that may make your head spin.
Wed, 01/12/2010 - 12:43 by Andrew Bond
Not too much has changed in Seth Klarman's portfolio over the past few months, according to his recent SEC filings. His top five positions remained the same during the third quarter. Klarman's Baupost Group did sell more than half of his large stake in paper producer Domtar (NYSE: UFS), and he added two new positions, in Alere (NYSE: ALR) andRegeneron Pharmaceuticals (Nasdaq: REGN).
Mon, 04/10/2010 - 23:49 by Prince damin
Paris -- French pharmaceutical giant Sanofi-Aventis said it would pursue biotechnology firm Genzyme even though discussions at the board level had ended.
Genzyme Chief Executive Officer Henri Termeer said the Sanofi-Aventis bid of $69 per share, an $18.5 billion offer "dramatically undervalues" the company, although the bid was a 31 percent premium over Genzyme's average stock price from June 22 through July 22.
The later date was the day before rumors of a potential deal were made public. Once word gets out of a possible deal, stock values can be influenced, which is which is why prices are often set at pre-rumor values.
Fri, 08/01/2010 - 15:12 by Ishita Sood
New York, January 8 -- The Environmental Protection Agency (EPA) on Thursday proposed stricter limits for the amount of pollution-forming smog, tightening previous rules made by the Bush administration.